Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.

If you have a press enquiry please visit our Press Office page.

Posted on 19 Jan

Alzheimer’s Research UK calls for post-Brexit plan to protect dementia research

Brexit must not delay the development and delivery of the first life-changing treatment for people living with dementia. That was the message Alzheimer’s Research UK had for politicians today during a roundtable hosted by the Exiting the European Union Committee. The meeting, held in Cambridge this afternoon, brought together pharmaceutical companies and research organisations to […]

Read more

Posted on 08 Jan

Top dementia research charity calls on pharma to stay the course

Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK. Recent news that Pfizer will refocus efforts away from dementia research is a reminder of one of the barriers that stands in the way of bringing about the […]

Read more

Posted on 13 Dec

Dementia deaths in Scotland now double 2007 figures

Deaths caused by dementia continue to rise across Scotland according to provisional figures released today by National Records of Scotland. The figures show deaths caused by Alzheimer’s and other dementias increased in the third quarter of 2017 by 13.6 per cent to 861. These deaths now account for 10 per cent of all deaths, doubled […]

Read more

Posted on 07 Dec

Alzheimer’s Research UK calls for global dementia commitment after WHO sounds the alarm

Alzheimer’s Research UK is calling for a renewed global commitment to treating dementia following new data from the World Health Organization (WHO) released today. The figures predict the number of people living with the condition will triple from 50 million to 152 million by 2050. This falls in line with data for the UK, where […]

Read more

Posted on 06 Dec

Leading dementia charity calls on government to include condition in future Life Sciences plans

Alzheimer’s Research UK is asking the government to give more priority to dementia as plans develop to support the Life Sciences sector. The Sector Deal announced today (6 December) represents yet another step forward by government to establish the UK as a global leader in health research. However, Alzheimer’s Research UK, the UK’s leading dementia […]

Read more

Posted on 01 Dec

NHS rationing reports are red flag for dementia treatment

Alzheimer’s Research UK, the UK’s leading dementia research charity, is calling on the government to protect dementia treatments as the NHS copes with future budget concerns. Reports in the media following yesterday’s NHS board meeting suggest that future treatments may be rationed due to budget constraints, including treatments for dementia, arthritis, hearing loss and blindness. […]

Read more

Posted on 27 Nov

Industrial Strategy offers opportunity to prioritise dementia research

Alzheimer’s Research UK is asking the government to increase financial support for dementia research as part of its Industrial Strategy plans. The Industrial Strategy white paper launched today outlines a commitment to research and development and the life science sector, and emphasises the need to support an ageing population. Alzheimer’s Research UK, the UK’s leading […]

Read more

Posted on 23 Nov

Autumn budget misses mark for dementia

Alzheimer’s Research UK is calling on the government to make continued commitments that support world-class research to address dementia – the leading cause of death in the UK and most feared condition of people over the age of 55. This comes in the wake of today’s budget announcement of plans to support sector growth through […]

Read more

Posted on 16 Nov

US study showing system not ready for next dementia treatment is warning for UK

The US healthcare system is not ready for potential breakthrough dementia treatments according to a new Rand Corporation study released yesterday. The study, commissioned by US biotechnology company Biogen, looked at the capacity of the current system to integrate new treatments. Alzheimer’s Research UK, the UK’s leading dementia research charity, is warning that similar roadblocks […]

Read more

Posted on 13 Nov

Dementia Discovery Fund attracts $50 million investment from Bill Gates

The Dementia Discovery Fund (DDF) today announces a $50 million investment from Bill Gates. The investment is Gates’ first to accelerate progress toward disease-modifying therapies for Alzheimer’s disease. The DDF, managed by SV Health, is a unique venture fund focused entirely on discovering and developing novel therapies for dementia and was formed through the collaboration […]

Read more

1 2 3 14